![Stephen M. Restaino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Stephen M. Restaino
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sonosa Medical, Inc.
![]() Sonosa Medical, Inc. Medical SpecialtiesHealth Technology Sonosa Medical, Inc. is a company that is developing the next generation of tools to diagnose and treat obstructive sleep apnea (OSA). The company is based in Baltimore, MD and was founded by Gilmer L. Blankenship, Stephen M. Restaino, and Jeffrey M. Wolf. OSA is a condition that affects nearly 1 billion people worldwide, causing partial or complete airway collapse during sleep, leading to frequent sleep disruptions and poor sleep quality. Sonosa Medical is developing a wearable ultrasound system to fundamentally change how OSA treatments are managed, providing a direct visual of obstructions during normal sleep, so clinicians can select the right treatment the first time. Stephen M. Restaino has been the CEO since incorporation. | Directeur Général | 01/11/2019 | - |
Fondateur | 01/11/2019 | - |
Historique de carrière de Stephen M. Restaino
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Chief Executive Officer | 1 |
Founder | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Sonosa Medical, Inc.
![]() Sonosa Medical, Inc. Medical SpecialtiesHealth Technology Sonosa Medical, Inc. is a company that is developing the next generation of tools to diagnose and treat obstructive sleep apnea (OSA). The company is based in Baltimore, MD and was founded by Gilmer L. Blankenship, Stephen M. Restaino, and Jeffrey M. Wolf. OSA is a condition that affects nearly 1 billion people worldwide, causing partial or complete airway collapse during sleep, leading to frequent sleep disruptions and poor sleep quality. Sonosa Medical is developing a wearable ultrasound system to fundamentally change how OSA treatments are managed, providing a direct visual of obstructions during normal sleep, so clinicians can select the right treatment the first time. Stephen M. Restaino has been the CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- Stephen M. Restaino
- Expérience